MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Seroquel 25mg tablets (Luye Pharma Ltd) and Quetiapine 25mg tablets (Accord Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Adcal 1500mg chewable tablets (Kyowa Kirin Ltd).

Stability Notes

Store in airtight containers. Protect from heat and moisture.

Provenance

Compatibility recommendation derived from Perindopril erbumine 2mg tablets (Sandoz Ltd).

Stability Notes

Store in airtight containers. Protect from heat and moisture.

Provenance

Compatibility recommendation derived from Perindopril erbumine 4mg tablets (Sandoz Ltd).

Stability Notes

Store in airtight containers. Protect from heat and moisture.

Provenance

Compatibility recommendation derived from Perindopril erbumine 8mg tablets (Sandoz Ltd).

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Hytrin 2mg tablets (Advanz Pharma).

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Hytrin 5mg tablets (Advanz Pharma).

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Hytrin 10mg tablets (Advanz Pharma).

Stability Notes

Protect from light. Protect from moisture. Store in airtight containers. Hygroscopic. Due to the hygroscopic nature of the tablets, maximum 8 day expiry in an MCA.

Provenance

This compatibility recommendation is derived from Prednisolone 1mg tablets (Accord Healthcare Ltd).

Stability Notes

Protect from light and store in airtight containers.

Provenance

Compatibility recommendation derived from Paracetamol 500mg caplets and 500mg tablets (Zentiva Pharma UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.